-transparent.png){kind=logo}
Pharmacokinetic studies with a new cardiac glycoside 3H-fluoro-alpha-acetyldigoxin were carried out in humans. The absorption of the drug is 91%. The half-life of tritium label in plasma was 25 h i.v. and 35 h p.o. 73% of the administered radioactivity were excreted after i.v. and 52% after oral administration within 84 h. More than 60% of the radioactivity in the urine could be extracted with chloroform. This fraction corresponded mainly to 3H-fluorodigoxin in the thin-layger chromatogram. Protein binding was 27% using therapeutic concentrations.
Related Publications
G Bodem, and
K Wirth, and
A Zimmer
March 1974,
Archiv der Pharmazie,
G Bodem, and
K Wirth, and
A Zimmer
May 1981,
Yao xue xue bao = Acta pharmaceutica Sinica,
G Bodem, and
K Wirth, and
A Zimmer
September 1979,
Zeitschrift fur Kardiologie,
G Bodem, and
K Wirth, and
A Zimmer
August 1977,
The Japanese journal of antibiotics,
G Bodem, and
K Wirth, and
A Zimmer
April 1976,
Nihon Funin Gakkai zasshi,
G Bodem, and
K Wirth, and
A Zimmer
June 1974,
Praktische Anasthesie, Wiederbelebung und Intensivtherapie,
G Bodem, and
K Wirth, and
A Zimmer
October 1981,
Deutsche medizinische Wochenschrift (1946),
G Bodem, and
K Wirth, and
A Zimmer
January 1982,
Arzneimittel-Forschung,
G Bodem, and
K Wirth, and
A Zimmer
January 1981,
Arzneimittel-Forschung,
G Bodem, and
K Wirth, and
A Zimmer
August 1978,
Kaku igaku. The Japanese journal of nuclear medicine,
